Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.transci.2021.103071 http://scihub22266oqcxt.onion/10.1016/j.transci.2021.103071 33518427!7839625!33518427     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Transfus+Apher+Sci 2021 ; 60 (3): 103071 Nephropedia Template TP {{tp|p=33518427|t=2021. COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review |pdf=|usr=}}{{33518427}} gab.com Text COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review JO: Transfus Apher Sci http://www.kidney.de/pget.php?&tw=1&pmid=33518427 #FOAvip The outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), generated an unprecedented global health and social emergency. Despite many efforts from clinicians to develop effective anti-COVID-19 treatment protocols, no specific therapy is currently available. Among anti-viral agents, convalescent plasma (CP) from recovered patients is the object of intense research following the first positive reports in severe COVID-19 patients. Passive immunotherapy the rationale to provide higher benefits in COVID-19 patients with humoral immune deficiencies, such as those with solid and hematologic cancers, patients with primary and acquired immunodeficiencies, and recipients of solid organ and hematopoietic stem cell transplants. The aim of this narrative review will be to critically discuss the literature evidence on CP use in these categories of patients. Twit Text FOAVip COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review ????Transfus Apher Sci http://www.kidney.de/pget.php?&tw=1&pmid=33518427 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33518427 #FOAvip English Wikipedia <ref>{{Cite pmid|33518427}}</ref> COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review #MMPMID33518427 Focosi D; Franchini M Transfus Apher Sci 2021[Jun]; 60 (3): 103071 PMID33518427show ga The outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), generated an unprecedented global health and social emergency. Despite many efforts from clinicians to develop effective anti-COVID-19 treatment protocols, no specific therapy is currently available. Among anti-viral agents, convalescent plasma (CP) from recovered patients is the object of intense research following the first positive reports in severe COVID-19 patients. Passive immunotherapy the rationale to provide higher benefits in COVID-19 patients with humoral immune deficiencies, such as those with solid and hematologic cancers, patients with primary and acquired immunodeficiencies, and recipients of solid organ and hematopoietic stem cell transplants. The aim of this narrative review will be to critically discuss the literature evidence on CP use in these categories of patients. |Antibodies, Neutralizing/*administration & dosage/blood[MESH] |COVID-19/immunology/*therapy/virology[MESH] |Humans[MESH]COVID-19 neutralizing antibody-based therapies in humoral immune defic(epmc).pdf DeepDyve Pubget Overpricing